Search

Nicoletta Sacchi

from North Potomac, MD
Age ~75
Get Report
Also known as:
Nicolett Sacchi
Phone and address:
11629 Happy Choice Ln, Gaithersburg, MD 20878
Connected to:
Darrell Sacchi, 44Diane M Sacchi, 65Gloria P Sacchi, 95Paulo S Sacchi, 67Veronica Sacchi, 41Paula J Sacchiero, 66Scott T Sacchieri, 37Marcy A Sacchini, 86Nancy E Saccio, 65Faith Saccketti, 44

Nicoletta Sacchi Phones & Addresses

  • 11629 Happy Choice Ln, Gaithersburg, MD 20878
  • North Potomac, MD
  • Buffalo, NY
  • Amherst, NY

Education

Degree: Graduate or professional degree

Resumes

Resumes

Nicoletta Sacchi Photo 1

Professor Of Oncology And Distinguished Member Of Cancer Genetics

View page
Location:
Buffalo, NY
Industry:
Hospital & Health Care
Work:
Roswell Park Cancer Institute - Buffalo, NY since Oct 2002
Professor of Oncology and Distinguished Member of Cancer Genetics
Johns Hopkins University - Baltimore, MD Aug 1998 - Sep 2002
Sydney Kimmel Cancer Center
Education:
Università Degli Studi Di Milano
Doctorates, Doctor of Philosophy, Genetics, Philosophy
Skills:
Cancer
Oncology
Molecular Biology
Cancer Research
Genetics
Cell Biology
Stem Cells
Micrornas
Epigenetics
Lon Non Coding Rnas
Nicoletta Sacchi Photo 2

Nicoletta Sacchi

View page
Location:
United States
Nicoletta Sacchi Photo 3

Professor Of Oncology At Roswell Park Cancer Institute

View page
Position:
Professor of Oncology at Roswell Park Cancer Institute
Location:
Buffalo/Niagara, New York Area
Industry:
Hospital & Health Care
Work:
Roswell Park Cancer Institute
Professor of Oncology

Publications

Us Patents

Aberrantly Methylated Genes As Markers Of Breast Malignancy

View page
US Patent:
6756200, Jun 29, 2004
Filed:
Jan 26, 2001
Appl. No.:
09/771357
Inventors:
Saraswati Sukumar - Columbia MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Assignee:
The Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RAR), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, and combinations of such genes serve as markers of breast malignancy.

Aberrantly Methylated Genes As Markers Of Breast Malignancy

View page
US Patent:
6835541, Dec 28, 2004
Filed:
Jan 28, 2002
Appl. No.:
10/059579
Inventors:
Saraswati Sukumar - Columbia MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Mary Jo Fackler - Hunt Valley MD
Assignee:
The Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RAR), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.

Aberrantly Methylated Genes As Markers Of Breast Malignancy

View page
US Patent:
7858317, Dec 28, 2010
Filed:
Oct 9, 2008
Appl. No.:
12/248793
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William C. Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Jo Fackler - Hunt Valley MD, US
Assignee:
Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/02
C07H 21/04
US Classification:
435 6, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARβ), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.

Method For The Rapid And Ultra-Sensitive Detection Of Leukemic Cells

View page
US Patent:
20030170715, Sep 11, 2003
Filed:
Mar 24, 2003
Appl. No.:
10/394192
Inventors:
Paul Nisson - Gaithersburg MD, US
Nicoletta Sacchi - Gaithersburg MD, US
Assignee:
Invitrogen Corporation
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
An improved method is disclosed for diagnosing the presence of a chromosomal translocation characteristic of acute myelogenous leukemia. Nucleic acid molecules that may be used in this improved method are described.

Aberrantly Methylated Genes As Markers Of Breast Malignancy

View page
US Patent:
20050191640, Sep 1, 2005
Filed:
Jun 18, 2004
Appl. No.:
10/872229
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Fackler - Hunt Valley MD, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARβ), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.

Method For The Rapid And Ultra-Sensitive Detection Of Leukemic Cells

View page
US Patent:
55478387, Aug 20, 1996
Filed:
Apr 19, 1994
Appl. No.:
8/230002
Inventors:
Paul E. Nisson - Gaithersburg MD
Nicoletta Sacchi - Gaithersburg MD
Assignee:
Life Technologies, Inc. - Gaithersburg MD
International Classification:
C12Q 168
C12P 1934
C07H 2100
US Classification:
435 6
Abstract:
An improved method is disclosed for diagnosing the presence of a chromosomal translocation characteristic of acute myelogenous leukemia. Nucleic acid molecules that may be used in this improved method are described.

Method For The Rapid And Ultra-Sensitive Detection Of Leukemic Cells

View page
US Patent:
58586636, Jan 12, 1999
Filed:
Jul 12, 1996
Appl. No.:
8/678854
Inventors:
Paul E. Nisson - Gaithersburg MD
Nicoletta Sacchi - Gaithersburg MD
Assignee:
Life Technologies, Inc. - Rockville MD
International Classification:
C12Q 168
C12P 1934
C07H 2102
C07H 2104
US Classification:
435 6
Abstract:
An improved method is disclosed for diagnosing the presence of a chromosomal translocation characteristic of acute myelogenous leukemia. Nucleic acid molecules that may be used in this improved method are described.
Control profile
Nicoletta Sacchi from North Potomac, MD, age ~75 Get Report